Rani Therapeutics Holdings, Inc. (RANI) Depreciation USD 2020 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Rani Therapeutics Holdings, Inc. annual/quarterly Depreciation history and growth rate from 2020 to 2023.
  • Rani Therapeutics Holdings, Inc. Depreciation for the quarter ending March 31, 2022 was $111 K, a 18.4% decline year-over-year.
  • Rani Therapeutics Holdings, Inc. annual Depreciation for 2023 was $800 K, a 60% increase from 2022.
  • Rani Therapeutics Holdings, Inc. annual Depreciation for 2022 was $500 K, unchanged from 2021.
  • Rani Therapeutics Holdings, Inc. annual Depreciation for 2021 was $500 K, a 15.1% decline from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $800 K +$300 K +60% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-20
2022 $500 K $0 0% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-20
2021 $500 K -$89 K -15.1% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 $589 K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.